About Axonics
Axonics develops the Axonics Sacral Neuromodulation System, an implantable device treating overactive bladder, bowel incontinence, and urinary retention. Notably, their long-lasting therapy boasts 93% patient response after 2 years and high satisfaction rates. Recently acquired by Boston Scientific for an undisclosed amount, Axonics previously secured $300M in funding and holds a specialized position in the sacral neuromodulation market. The company focuses on providing a discreet and clinically proven alternative to traditional therapies.
Key Products & Services
Axonics Sacral Neuromodulation System
Industry Sectors
Founded
2012
Funding
$300M
Quick Links
Company Details
- Country
- United States
- City
- Irvine
- State
- California
- Type
- commercial
- Stock
- AXNX
